[3dem] Reminder: Electron microscopist position with Boehringer Ingelheim and the IMP

[Haselbach,David]

Dear all,


Boehringer Ingelheim in cooperation with The Research Institute for Molecular Pathology (IMP) offers a position for a highly motivated cryo electron microscopist.



Our Set-up.
Boehringer Ingelheim and the IMP recently purchased a Titan Krios G4 to complete the existing cryo set-up including a Glacios and several sample preparation devices and are looking for a highly motivated electron microscopist.

The Tasks. The successful candidate's tasks will include

  *   Operation of both the Krios and Glacios for IMP and BI samples
  *   Maintenance of the Krios
  *   Initial image processing
  *   Training of users identifying and establishing of new methods and approaches for the Krios
  *   Work on pre-competitive industry projects and basic research projects together with BI and IMP scientists with possibility to publish results

The Candidate. The successful candidates should be:

  *   Independent
  *   Ideally hold a PhD degree in the fields of cryo electron microscopy or have at least 5 years of experience in operating a cryo electron microscope
  *   Experience in alignment, manual and automated data acquisition as well as data processing for single particle EM
  *   Experience in cryo electron tomography is highly desirable

The Position

  *   The position will be initially a fixed term position for 5 years, however after this period it is possible that the position gets prolonged or gets permanent.
  *   The salary will be on postdoc level, but can be further negotiated based on experience.



  *   The successful candidate should ideally join in summer 2021.


Our Environment.
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. The IMP is located at the Vienna BioCenter, one of Europe’s most dynamic life science hubs with 1,850 employees from 70 countries in four research institutes, three universities and over 30 biotech companies. A special feature of this position is the close interaction with applied pharma research which will give the successful candidate valuable insights into the workflows and strategies of drug discovery. https://urldefense.com/v3/__http://www.imp.ac.at__;!!Mih3wA!RzeaWrmVKLgZPO4T432dUizntsy1cEvqU8HvkV3Sq3nK5jdoBlJZLm035aiVbZEY7w$ <https://urldefense.com/v3/__http://www.imp.ac.at/__;!!Mih3wA!RzeaWrmVKLgZPO4T432dUizntsy1cEvqU8HvkV3Sq3nK5jdoBlJZLm035agEvY69Sw$ >, https://urldefense.com/v3/__http://www.viennabiocenter.org__;!!Mih3wA!RzeaWrmVKLgZPO4T432dUizntsy1cEvqU8HvkV3Sq3nK5jdoBlJZLm035ajpE-4k6A$ <https://urldefense.com/v3/__http://www.viennabiocenter.org/__;!!Mih3wA!RzeaWrmVKLgZPO4T432dUizntsy1cEvqU8HvkV3Sq3nK5jdoBlJZLm035aixzzHN1Q$ >

Application. Interested candidates should send their application (motivation letter, CV, contact details of two references) by email to david.haselbach at imp.ac.at<mailto:david.haselbach at imp.ac.at>. The call will be open until the position is filled. The application screening will start February 1st 2021 to be considered for this round applications should be sent by January 31st 2021 at the latest.
Please also feel free to contact me directly.

Kind regards

David Haselbach
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.ncmir.ucsd.edu/pipermail/3dem/attachments/20210115/7e05040b/attachment-0001.html>